Enabling next-generation analysis of rare cells with an open and end-to-end platform that supports clinical trials worldwide

News & Events

RareCyte® announces the CyteFinder® II and CyteFinder II HT Instruments in conjunction with the American Association for Cancer Research Annual Meeting in Atlanta, March 29 through April 3.
more →

Meet the RareCyte team at ASCO
01-03 June 2019
Chicago, IL
Booth #19077
more →


RareCyte expands its world-class liquid biopsy imaging and retrieval platform to support tissue workflows with the new CyteFinder II Instruments.

more →

RarePlex CTC Developer Staining Kit enables custom CTC assay development by providing the ability to add up to two biomarkers-of-interest to the CTC base detection assay.

more →

Pharma Programs

RareCyte Pharma Programs support pharma development through our expert product development teams. Our services span the range from RUO product development for pre-clinical and clinical research to IVD support for companion diagnostic co-development.

more →